A report about treatment refusal and abandonment in children with acute lymphoblastic leukemia in China, 1997-2007

Yan-rong Wang1, Run-ming Jin, Jia-wei Xu

  • 1Department of Pediatrics, The Affiliated Shenzhen Third Hospital, Guangdong Medical College, Shenzhen, China. 123rong@sohu.com

Leukemia Research
|August 2, 2011
PubMed

Insights

High rates of treatment refusal and abandonment were observed in childhood acute lymphoblastic leukemia (ALL) patients in China. Financial difficulties and perceived incurability were key reasons, highlighting the need for improved healthcare access and education.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Public Health

Background:

  • Childhood acute lymphoblastic leukemia (ALL) presents significant treatment challenges.
  • Treatment refusal and abandonment are critical issues impacting patient outcomes.
  • Understanding the specific barriers in diverse healthcare settings is essential.

Purpose of the Study:

  • To investigate the causes and consequences of treatment refusal and abandonment in childhood ALL.
  • To identify key factors contributing to therapy non-adherence in a Chinese population.
  • To inform strategies for improving treatment completion rates in pediatric ALL.

Main Methods:

  • Retrospective analysis of medical records for childhood ALL patients diagnosed between 1997 and 2007.
  • Interviews with families of children who refused or abandoned treatment.
  • Telephone and mail follow-up assessments to determine patient status.

Main Results:

  • Over half (53.6%) of diagnosed children refused therapy, and 10.8% abandoned treatment.
  • Major reasons for refusal/abandonment included financial difficulties, belief in incurability, transportation issues, and fear of side effects.
  • Survival rates were very low for children who refused (6.3% alive) or abandoned (6.5% alive) treatment.

Conclusions:

  • Significant barriers to consistent treatment for childhood ALL exist.
  • Financial constraints and health beliefs strongly influence treatment adherence.
  • Systemic health education and medical insurance are crucial for improving outcomes in low-middle income countries.
Abstract